| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-15 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-14 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-14 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-13 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-12 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-11 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.22 | 9e-10 |